Anskaffelser: Nasjonalt Folkehelseinstitutt (The Norwegian Institute of Public Health)
2 arkiverte anskaffelser
Nasjonalt Folkehelseinstitutt (The Norwegian Institute of Public Health) har historisk anskaffet medisinsk utstyr, legemidler og utstyr til personlig pleie, farmasøytiske produkter og antiinfektive midler for systemisk bruk, vaksiner, cytostatika/cytotoxiske midler, samt immunmodulerende midler.
Nyeste anskaffelser av Nasjonalt Folkehelseinstitutt (The Norwegian Institute of Public Health)
2015-05-20
Framework agreement regarding the purchase of consultancy services Agresso (Nasjonalt Folkehelseinstitutt (The Norwegian Institute of Public Health))
The Norwegian Institute of Public Health (FHI) wishes through this tender contest, to enter into a framework agreement with 1 provider who can support the requirement for facilitating and further developing the Agresso financial management system in accordance with the contracting authority's requirements. This includes general consultancy assistance, basic support, implementation of new modules, preliminary project upgrading, and upgrading and equivalent services. Vis anskaffelsen »
The Norwegian Institute of Public Health (FHI) wishes through this tender contest, to enter into a framework agreement with 1 provider who can support the requirement for facilitating and further developing the Agresso financial management system in accordance with the contracting authority's requirements. This includes general consultancy assistance, basic support, implementation of new modules, preliminary project upgrading, and upgrading and equivalent services. Vis anskaffelsen »
2015-04-24
A combination vaccine against diphtheria, tetanus, pertussis, polio, Hib and hepatitis B (Nasjonalt Folkehelseinstitutt (The Norwegian Institute of Public Health))
The Norwegian Institute of Public Health shall enter into an agreement regarding the purchase of a combination vaccine for the diseases diphtheria, tetanus, pertussis, polio, Hib and hepatitis B (a six component vaccine), for the National Vaccine Programme The six component vaccine shall replace the existing five component vaccine (diphtheria, tetanus, pertussis, polio and Hib). It shall also partly replace the vaccine against hepatitis B for defined risk groups. The six component vaccine is expected to … Vis anskaffelsen »
The Norwegian Institute of Public Health shall enter into an agreement regarding the purchase of a combination vaccine for the diseases diphtheria, tetanus, pertussis, polio, Hib and hepatitis B (a six component vaccine), for the National Vaccine Programme The six component vaccine shall replace the existing five component vaccine (diphtheria, tetanus, pertussis, polio and Hib). It shall also partly replace the vaccine against hepatitis B for defined risk groups. The six component vaccine is expected to … Vis anskaffelsen »